Mesenchymal Expression of CD90 and Nuclear Expression of FOXM1 Correlate With Disease Progression in Hepatocellular Carcinoma

被引：0
|
作者：
Ronquillo, Nemencio
Sun, Belinda
Xie, Hui
Raychaudhuri, Pradip
Guzman, Grace
机构：
[1] Univ Illinois Hosp & Hlth Sci Syst, Chicago, IL USA
[2] Univ Illinois, Chicago, IL USA
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
742
引用
收藏
页码：187A / 188A
页数：2
相关论文
共 50 条
  • [21] Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibition of mesenchymal cancer stem cells characterized by the expression of CD90
    Mariko Yoshida
    Taro Yamashita
    Hikari Okada
    Naoki Oishi
    Kouki Nio
    Takehiro Hayashi
    Yoshimoto Nomura
    Tomoyuki Hayashi
    Yoshiro Asahina
    Mika Ohwada
    Hajime Sunagozaka
    Hajime Takatori
    Federico Colombo
    Laura Porretti
    Masao Honda
    Shuichi Kaneko
    Scientific Reports, 7
  • [22] Comparison of clinicopathological parameters with FoxM1 expression in renal cell carcinoma
    Kocarslan, Sezen
    Guldur, Muhammet Emin
    Ekinci, Turan
    Ciftci, Halil
    Ozardali, Hasan Ilyas
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (04) : 1076 - 1081
  • [23] A reduction in CD90 (THY-1) expression results in increased differentiation of mesenchymal stromal cells
    Daniela A. Moraes
    Tatiana T. Sibov
    Lorena F. Pavon
    Paula Q. Alvim
    Raphael S. Bonadio
    Jaqueline R. Da Silva
    Aline Pic-Taylor
    Orlando A. Toledo
    Luciana C. Marti
    Ricardo B. Azevedo
    Daniela M. Oliveira
    Stem Cell Research & Therapy, 7
  • [24] Thyroid hormones suppress FOXM1 expression to reduce liver cancer progression
    Wu, Cheng-Heng
    Yeh, Chau-Ting
    Lin, Kwang-Huei
    ONCOLOGY REPORTS, 2020, 44 (04) : 1686 - 1698
  • [25] LncRNA MALAT1 acts as a miR-125a-3p sponge to regulate FOXM1 expression and promote hepatocellular carcinoma progression
    Liu, Shihai
    Qiu, Jing
    He, Guifang
    Liang, Ye
    Wang, Liping
    Liu, Changchang
    Pan, Huazheng
    JOURNAL OF CANCER, 2019, 10 (26): : 6649 - 6659
  • [26] Aberrant FoxM1 expression increases ASPM transcription and promotes progression of gliomas
    ZENG Wen-jing
    WEN Zhi-peng
    GONG Zhi-cheng
    CHEN Xiao-ping
    中国药理学与毒理学杂志, 2019, (10) : 892 - 892
  • [27] A reduction in CD90 (THY-1) expression results in increased differentiation of mesenchymal stromal cells
    Moraes, Daniela A.
    Sibov, Tatiana T.
    Pavon, Lorena F.
    Alvim, Paula Q.
    Bonadio, Raphael S.
    Da Silva, Jaqueline R.
    Pic-Taylor, Aline
    Toledo, Orlando A.
    Marti, Luciana C.
    Azevedo, Ricardo B.
    Oliveira, Daniela M.
    STEM CELL RESEARCH & THERAPY, 2016, 7
  • [28] Correlation among the expression of CD133, CD90, and poor survival outcome in hepatocellular carcinoma: a meta-analysis
    Hu, Yuxue
    Li, Xiaoyan
    Gao, Jian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (04): : 2965 - 2977
  • [29] FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1
    Yu, Chun-Peng
    Yu, Shui
    Shi, Lei
    Wang, Song
    Li, Zi-Xiang
    Wang, Yan-Hua
    Sun, Cheng-Jian
    Liang, Jun
    MOLECULAR MEDICINE REPORTS, 2017, 16 (04) : 5181 - 5188
  • [30] FoxM1 Epigenetically Represses Expression of the Developmental Genes FoxA1/A2 in Aggressive Hepatocellular Carcinoma
    Pandey, Akshay
    Chand, Vaibhav
    Kopanja, Dragana
    Guzman, Grace
    Raychaudhuri, Pradip
    HEPATOLOGY, 2016, 64 : 264A - 264A
12345